During the past decade, Anapharm Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anapharm Inc." #1 collaborator was "Ionis Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Anapharm Inc." are "Healthy" (12 trials) and "Healthy Volunteer" (1 trials). Many other conditions were trialed in "Anapharm Inc." in a lesser frequency.

Most popular intervention types in "Anapharm Inc." are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "Altace® 10 mg capsule" (3 trials), "Ramipril 10 mg capsule" (3 trials), "Amlodipine-benazepril 10 mg-20 mg capsules" (2 trials), "Effexor® 25 mg Tablets" (2 trials) and "Lotrel® 10 mg-20 mg capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "Anapharm Inc." are 12 trials for "All" genders.

Currently, there are NaN active trials in "Anapharm Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Anapharm Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Anapharm Inc., 13 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".